Loading...

World-Class Retina Care. Community-Based Caring.

Texas Retina Associates First in the Country to Dose a Patient in the DAVIO 2 Clinical Trial

Posted On August 8, 2022 / By / Posted in Blog

Texas Retina Associates First in the Country to Dose a Patient in the DAVIO 2 Clinical Trial

Texas Retina Associates is honored to have randomized the first patient in EyePoint Pharmaceuticals’ Phase 2 “Durasert and Vorolanib in Ophthalmology 2” (DAVIO 2) clinical trial of EYP-1901 for patients with wet macular

read more